CASO CLÍNICO
4.2 Construcción del caso
4.2.3 Los carritos son torpes
These 2 groups can then be compared for the independent predictors/risk factors. The predictors of death can then be ascertained in Nigerians with HF.
In addition, further studies should ensure a complete diastolic function assessment by performing both tissue doppler imaging and pulmonary venous blood sampling.
REFERENCES
1. Hunt SA, Baker DW, Chin ML, et al: Report of the ACC/ AHA Guidelines for the Evaluation and Management of chronic Heart Failure in the Adult. Circulation 2001; 104; 2996.
2. Ho KK, Pinsky JL, Kannel WB,et al : The epidemiology of heart failure: The Framingham study. J Am coll cardiol 2001; 22:6A.
3. American Heart Association: 2004 Heart and stroke statistical update ; Dallas, American Heart Association, 2004
4. Oyoo GO, Ogola EN. Clinical and sociodemographic aspects of congestive heart failure patients at kenyatta National Hospital, Nairobi: East Afr med J 1996; 76:
23- 7
5. Teerlink JR, Goldhaber SZ, Pfeffer MA: An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991;121(6pt 1):1852-1853.
6. Kadiri S, Walker O, Salako BL Akinkugbe O. Blood pressure, hypertension and correlates in urbanized workers in Ibadan, Nigeria: a revisit. J Hum Hypertens.
1999; 13(1): 23- 7.
7. Obasohan AO, Ajuyah C.O. How common is heart failure due to systemic hypertension alone in hospitalized Nigerians? J Hum Hypertens, 1996 Dec;
10(12): 801-4.
8. Balogun MO Hypertension and Heart failure. Nigerian Journal of Health Sciences. 2002; 2:1-6.
9. Abengowe CU. Cardiovascular disease in Northern Nigeria. Trop Geogr Med 1979 Dec; 31(4): 553- 60.
10. Araoye MA, Olowoyeye O. The clinical spectrum of hypertensive heart failure;
point–score system for solving an old problem; E Afr. Med. J 1984; 61: 306-15.
11. Katz AM: Heart failure. Philadelphia, Lippincott Williams & wilkins, 2000 12. Feigenbaum H: clinical applications of echocardiography progr cardiovasc Dis
1972; 14: 531- 558.
13. Balogun MO; Omotoso AB, Bello E et al: An audit of emergency echocardiography in a district general hospital. International Journal of cardiology; 41:65-68
14. Mc Henry MM. Medical screening of patients with coronary heart disease: criteria for entry into exercise conditioning programs. Am.J Cardiol 1974: 33: 752 – 56.
15. Fortuin NJ and Weiss JL . Exercise stress testing. Circulation 1977; 56: 695-712.
16. Cahalin LA, Mathier MA, semigram MJ, DecGW, Disalvo TG. The six minute walk test predicts oxygen uptake and survival in patients with advanced Heart Failure. Chest 1996 Vol 110, 325- 332.
17. Cowie MR, wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: A population based study. Heart 2000; 83: 505 –10.
18. Levy D, Kencahiah S, Larson MG, et al: Long- term trends in the incidence of and survival with heart failure. N Engl J Med 2002 347: 1397.
19. Rose EA, Gelijns AC, Moskowitz AJ, et al: Long term mechanical left ventricular assistance for end-stage heart failure. N Engl J med 2001 345: 1435.
20. Simon T, Mary-Krause M, Funck – Brentano C: Sex differences in the prognosis of congestive heart failure: Results from the cardiac Insufficiency Bisopodol study (CIBIS II). Circulation 2001; 103: 375.
21. Bart BA, Shawn LK, McCants CB Jr, et al: Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am coll cardiol 1997; 30:1002.
22. Drazner MH, Rame JE, Stevenson LW: prognostic importance of elevated jugular venous pressure and a third sound in patients with heart failure . N Engl J Med 201; 345: 574.
23. Chomsky DB, Lang CC, Rayos GH, et al: Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation 1996; 94: 3176.
24. Pardaens K, Van cleemput J, Vanhaecke J: Peak oxygen uptake better predicts outcome than submaxiaml respiratory data in heart transplant candidates.
Circulation 2000, 101-1152.
25. Metra M, Faggiano P, D’Aloia A, et al: Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol 1999;33:943
26. Hammermeister KE, Chikos PM, Fisher L: Relationship of cardiothoracic ratio and plain firm heart volume to late survival. Circulation 1979; 59:89-95.
27. Vasan RS, Larson MG, Benjamin EJ, et al: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort-J Am Coll Cardiol 1999; 33:1948.
28. Meeney D and Sherif F. Echocardiography and prognosis of heart failure.Curr Opin Cardiol 2002,17:253-256
29. Sharma R, Rauchhaus M, Ponikowski PP, et al: The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cordiol 2000;36:523.
30. La Rovere MT, Pinna GD, Maestri R, et al: Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.
Circulation 2003;107:565.
31. Singh SN, Fisher SG, Carson PE et al: Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT investigators. J Am Coll Cardiol 1998;32:942.
32. Juliano S, Fisher SG, Karasik PE, et al: QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002;143:1085.
33. Dries DL, Exner DV, Gersh BJ, et al: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J AM Coll Cardiol.1998;32:695.
34. Vrtovec B, Delgado R, Zewail A, et al: Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation 2003; 107:1764.
35. Pinsky DJ, Sciacca RR, Steinberg JS: QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol.1997; 29:1576.
36. Bouvy ML, Heerdink ER, Leufkens HG: Prediction of mortality in patients with heart failure: a pragmatic approach. Heart 2003; 89:605-609.
37. Fonarow GC, Adams Jr KF, Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in Acutely Decompensated Heart Failure;
Classification and Regression Tree Analysis. JAMA 2005;293:572-580.
38. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries; a review of the literature. Int J Cardiol 2001;80:213-219.
39. Agarwal Ak, Venugopalan P, de Bono D: Prevalence and aetiology of Heart Failure in an Arab population. Eur J Heart Failure.2001;3301-05.
40. Centers for Medicare and Medicaid Services; 2002 Data Compendium Baltimore 2002.
41. O’Connell JB, Bristow MR: Economic impact of heart failure in the United States; Time for a different approach. J. Heart Lung Transplant 13:S107, 1994.
42. Kannel WB; Belanger AJ: Epidemiology of heart failure 199; 121 (3pt 1):951-7.
43. Rotimi O, Ajayi AA, Odesanmi WO. Sudden Unexpected death from cardiac causes in Nigerians: A review of 50 autosied cases. Int J Cardiol. 1998; 63:111-115.
44. Falase A.O, Ayeni O, Sekoni G.A, Odia OJ. Heart Failure in Nigeria hypertensives. Afr. J. Med Sci 1983; 12(1):7-15.
45. Olubodun J O Nutritional factors and heart failure in Nigerians with hypertensive heart disease. Int J Cardiol.1992 Apr; 35(1):71-6.
46. Cooper R, Rotimi C, Atmans S, McGee D, Osotimehin B, et al The Prevalence of hypertension in seven populations of West African Origin. Am J Public Health, 1997;87 (2):!55-6.
47. Cooper R, Charles N, Rotimi C, Polymorphism of renin-angiotensinogen genes among Nigerians, Jamaicans and African Americans.Hypertension.1996;127(3) 558-63.
48. Amoah AJB, Kallen C, Aetiology of heart failure as seen from a national cardiac referral center in Africans. Cardiology 2000;93:11-18.
49. Ho KL, Pinsky JL kannel WB, Levy D: The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993; 22(Suppl A):6A
50. Balogun MO, Langhorne P, Dunn FG: Electrocardiographic and echocardiographic assessment of two patients with lyme disease in whom diagnosis and treatment were delayed. Tropical Cardiology.1996; 22:25-28.
51. Langhorne P, Balogun M, Dunn FG, Fyfe T, Walker E. Unexpected cardiac abnormalities in lyme disease.1993.BMJ;307:736-737.
52. Cerqueira MD, Weissman NJ, Dilsizian V et al; Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Circulation 2002.105:539.
53. De Maria AN, Wisebangh TW, Smith MD: Doppler echocardiographic evaluation of diastolic dysfunction. Circulation 1991:84(suppl I) I288-I295.
54. Balogun MO Assessment of left ventricular Diastolic function in cardiovascular Disease.Nigeria Journal of Health Sciences 2001;1:30-35.
55. Feigenbaum’s Echocardiography. 6th ed. Lippincott & Wilkins,2005: 529-537 56. Pai RG, Buech GC. New Doppler measures of left ventricular diastolic function.
Clin Cardiol 1996:19:227-88.
57. Zile MR, Brutsaert DL: New Concepts in diastolic dysfunction and diastolic heart failure: Part 1: Diagnosis, prognosis and measurements of diastolic function.Circulation.2002:105:1387.
58. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobson SJ, Evans JM, Bailey KR, Redfield MM: Congestive heart failure in the community: a study of all incident cases in olmstead county, Minesota, in 1991. circulation 1998, 98: 2282- 2289.
59. Ike S. O, Onwubere BJ. The relationship between diastolic dysfunction and level of blood pressure in blacks. Ethn Dis. 2003; 13(4): 463-9.
60. Balogun MO, Urhoghide GE, Ukoh VA and Adebayo RA. A preliminary Audit of Two Dimensional and Doppler Echocardiographic Service in a Nigerian Tertiary private Hospital. Nigerian Journal of Medicine . 1999; 8: 139- 141
61. Balogun MO, Dunn FG. Systolic and Diastolic Function following Regression of left ventricular Hypertrophy in hypertension. Journal of hypertension. 1991; 9:51-55
62. Lawal SOA, Falase AO. The Effect of Hypertension on the heart of Adult Nigerians. Tropical Cardiology. 1998; 14: 153-159.
63. Bruce R.A. Exercise testing and exercise training in coronary heart disease.
Principles of exercise testing. Academic pres, New York 1973. pg 45.
64. Guyatt GH, Sullivan MJ, Thompson PJ et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med. Asoc J 1985;
132: 919-923.
65. Lipkin DP, Scriven AJ, Crake T et al Six minute walking Test for assessing exercise capacity in chronic heart failure. Br Med J (clin Res Ed) 1986; 292: 653-655.
66. Kosak M, Smith T. Comparison of the 2,6, and 12 minute walk test in patients with stroke. J stroke cerebrovasc. Dis 2000; 9:201.
67. Cooper KH. A means of assessing maximal oxygen uptake. Journal of the American medical Association. 1968; 203; 201-204.
68. Minino AM, AriasE, Kochanek KD, et al: Deaths; Final Data for 2000. National vital statistics Reports. Vol 50, No 15. Hyattsville, Md, National Center for Health statistics, 2002.
69. Ho KK, Anderson KM, Kannel WB, et al: Survival after the onset of congestive heart failure in Framingham Heart study subjects. Circulation 1993; 88:107 70. The criteria committee of the New York Heart Association: Nomenclature and
criteria for Diagnosis of Diseases of the Heart and Great vessels. 9th ed. Boston, Little, Brown, 1994.
71. Cohn JN, Rector TS . Prognosis of congestive heart failure and predicators of mortality. Am J cardiol 1988; 62(2) : 25A- 30A.
72. Bittner V, Weiner DN, Yusuf S, et al for the SOLVD Investigators. Prediction of mortality and morbidity with a 6- minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270: 1702- 1707.
73. Graman AH, Deedwania PC. Predictors of mortality in patients with heart failure.
Cardiol Clin. 1994; 12(1) 25-35.
74. Dries DL, Sweitzer NK, Drazner MH, et al; Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction J. Am Coll Cardiol 2001: 38:421.
75. Anker SD, Negasa A, Coats AJ, et al: Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin – converting enzyme inhibitors; An observational study. Lancet 2003; 361: 1077.
76. Trichon BN, Felker GM, Shaw LK, et al : Relation of frequency and severity of mitral regulation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J cardiol 2003; 91:538- 543.
77. Drodz J, Krzeminska – Pakula M,. Ciesialczyk M, kasprzak JD: prognostic value of low-dose dobutamine echocardiography in patient with idiopathic dilated cardiomyopathy. Chest 2002; 121: 1216- 1222.
78. Keogh AM, Baron DW, Hickie JB, Prognostic guide in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J cardiol 1990; 65: 903.
79. Cohn JN, Levine TB, Olivari MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J med 1984;
311: 819- 823.
80. Gottieb SS, Kukin ML, Ahern D et al. Prognostic importance of Atrial natriuretic peptide in patients with chronic heart failure. J Am Coll cardiol 1989; 13: 1534- 1538.
81. Lee WH, Packer M. prognostic importance of serum sodium concentration and its modification by angiotensin converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73:257.
82. Hare JM, Johnson RJ: Uric acid predicts clinical outcomes in heart failure:
Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology circulation 2002; 107: 1951.
83. Hoerwich TB, Fonarow GC, Hamilton MA, et al: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll cardiol 2002; 39:1780.
84. Stevenson WG, Stevenson LW, middlekauff HR, et al Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll cardiol 1996;
28:1458.
85. Isezuo AS, Omotoso AB, Araoye MA et al. Determinants of prognosis among black Africans with hypertensive heart failure. Afr. J Med Sci. 2003; 32(2): 143-9.
86. Obasohan A.O, Ajuyah CO: Heart failure in Nigerian hypertensives. The role of renal dysfunction. Int J cardiol 1995; 52(3) : 251-5.
87. Christopher H. Cabell, Benjamin H, et al Importance of Echocardiography in patients with severe Nonishemic Heart failure: The second prospective Randomised Amlodipine survival Evaluation. (PRAISE –2) Echocardiographic study. Am Heart J 2004 147(1) : 151- 157.
88. Consensus recommendation for the management of chronic heart failure. Am J cardiol 1999: 83(2A): IA- 38A.
89. Betkowski AS, and Hauptman PJ. Update on Recent clinical trials in congestive heart failure. Current opinion in cardiology 2000; 15: 293-303.
90. Ajayi AA, Balogun MO, Oyewo EA et al. Enalapril in African Patients with congestive cardiac failure. British Journal of clinical pharmacology 1989; 27:
400- 405.
91. Ajayi AA, Osodi OO, Akintomide AO. The influence of captopril on intrahospital mortality and duration of hospitalization in Nigerians with congestive heart failure. Int J cardiol 1992; 36(3) 341-3.
92. Ajayi AA Balogun MO Sustained Beneficial effects of Enalapril in Africans with Congestive Heart Failure. Int. J. Cardiol 1990; 29:55-61.
93. Adewole AD, Ikem RT, Adigun AQ, Akintomide AO, Balogun MO and Ajayi AA. A three year clinical Review of the impact of Angiotensin Converting Enzyme Inhibitors on the intrahospital mortality of congestive heart failure in Nigerians. Central African Journal of Medicine 1996; 42:253-255.
94. Pitt B, Zannad F, Remme W, et al for the Randomized Aldactone Evaluation study (RALES) Investigators. N Engl J Med 1999; 341: 709-17.
95. Mc Murry J: Major beta blocker mortality trials in chronic heart failure: a critical review. Heart 1999; 82 14- 22.
96. The effect of digoxin on mortality and morbidity in patients with heart failure.
The Digitalis Investigation Group. N Engl J med 1997; 336(8) : 525-33.
97. Definition and classification of stages of chronic kidney disease.Am J Kidney Dis 39(Suppl 1):46-75
98. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976:16:31-41.
99. Flegal KM, Carrol MD, Ogden Cl, : Prevalence and trends in obesity among U.S adults.JAMA 2002;228:1723-1727.
100. Davies RC, Hobbs FDR, Kenkre JE, et al: Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study. BMJ 2002 November 16;325(7373):1156
101. American Association of Cardiovascular and Pulmonary Rehabilitation Guidelines for Pulmonary rehabilitation programs, 2nd ed. Champaign (IL):
Human Kinetics Publishing; 1998 P 57-59.
102. Sahn DJ, DeMaria A, Kisslo J, et al: The committee on M-mode standardization of the American Society of Echocardiography: Results of a survey of Echocardiographic measurements. Circulation 1978; 58 (6):1072-1083.
103. Teichhoiz LE, Kreulen T, Herman MV, et al: Problems in echocardiographic-angiographic correlation in The presence or absence of asynergy-Am J Cardiol 1976; 37:7-11.
104. Deuvereux RB, Alonso DR, Lutas EM, et al Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol.1986;57:450-458
105. Mc Murray JV, Petrie MC, Murdoch DR et al : Clinical epidemiology of heart failure ; public and private health burden. Eur Heart J 1998: 19 (Suppl):9-16
106 Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class 4 symptoms of heart failure. Am Heart J.2000 ; 140 (6): 840-7
107 Cowie MR, Wood DA, Coats AJ, et al Survival of patients with a new diagnosis of heart failure :a population based study. Heart 2000;83:505-10
108 Levin A. Thompson CR, Ethier J. et al. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am. J. Kidney Dis. 1999;
34; 125.
109 Kearney MT, Fox KA, Lee AJ et al: Predicting death due to progressive heart failure in patients with mild- to- moderate chronic heart failure. J Am Coll Cardiol.2002;40 (10):1801-8
110 Koelling TM, Aaranson KD, Cody RJ et al. prognostic significance of MR and TR in patents with left ventricular systolic dysfunction. An Heart J. 2002; 144:
524-529.
111 Rihal CS, Nishimura RA, Hattle LK, et al systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis. Circulation 1994, 90:2772-2779.
112 Xie GY, Berk MR, Smith MD et al. Prognostic valve of doppler transmitral flow patterns in patients with congestive heart failure. J. Am. Coll. Cardiol. 1994;24:
132-139.
113 Yong Y, Naguech SF, Shimoni S, et al: deceleration time in Ischemic cardiomyopathy, relation to echocardiographic and scintigraphic indices of
myocardial viability and functional recovery after revascularization. Circulation 2001, 103:1232-1237.
114 Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure- abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350 :1953-9
115 Zile MR Gaasch WH, Carroll JD, et al Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001; 104:779-82
116 Sangeeta G, Sujatha B, Steve B, et al: Predictors Of Death Or Readmission In African-Americans And Hispanics Hospitalized For Congestive Heart Failure In An Inner City Hospital.. The Internet Journal of Cardiology. 2006; ( 3)1.
117 Davos CH, Doehner W, Rauchhaus M, et al: Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003 Feb; 9(1): 29-35
118 Ogunnowo P.O., Odesanmi W.O., Andy J. Coronary artery pathology of three consecutive Nigerians. Trans. R. Soc. Trop. Med. Hyg. 1986; 80: 923-926.
119 Heywood J, Wafaa E, et al. Simple clinical criteria to determine the prognosis of heart failure. Journal of cardiovascular Pharm. and Therapeutics 2005;10; 173-180.
120 Vaccarino V, Gahbauer E, Kasl SV, et al: Differences between African Americans and whites in the outcome of heart failure: Evidence for a greater functional decline in African Americans. Am Heart J. 2002 Jun; 143(6): 1058-67
121 Cohn JN, Johnson G, Heart failure with normal ejection fraction: the V-HeFT study. Veterans Administration Cooperative study group. Circulation 1990;
81:48-53
122 Adelino F: Current perspectives in systolic dysfunction and diastolic heart failure.
Heart 2006; 92: 712-718.
123 Balogun MO, Ajayi AA, Ladipo GO. Spectrum of treadmill exercise responses in Africans with normotensions essential hypertension and hypertensive heart failure. Int. J. Cardiol. 1998; 21: 293-300.
PROFORMA (APPENDIX 1)
Name: Hospital No
Age: X ray No
Gender: Phone Number
Occupation Religion
Marital Status: Educational Status
Address: Clinic/Ward Date PRESENTATING COMPLAINTS
Dyspnea on Exertion Yes/No Pedal Swelling Yes/No Orthopnea Yes/No Abdominal swelling Yes/No PND Yes/No Early satiety Yes/No Cough Yes/No Facial Swelling Yes/No Palpitation Yes/No Decreased Urine output Yes/No Chest Pain Yes/No PAST MEDICAL HISTORY
Hypertension Yes/No DURATION
Diabetes Yes/No DURATION
Pulmonary disease Yes/No DURATION Previous Stroke Yes/No
Arthritis Yes/No
SOCIAL HISTORY
Alcohol Yes/No QUANTITY DURATION
Cigarette Yes/No QUANTITY DURATION
Drug Use Yes/No TYPE DURATION
CLINICAL EXAMINATION Weight Loss
Jaundice
Cyanosis Central Peripheral Pedal Swelling
Cold Extremeties Yes/No Asterixis Yes/No CARDIOVASCULAR SYSTEM
Pulse Rate Volume Rhythm
Blood pressure on Admission Pulse pressure on Admission
Jugular Venous Pressure Elevated/not Elevated Apex Beat Location
Aortic ValveClosure Pulmonic Valve Closure Third Heart Sound
Basal Crepitations Yes/No Tender Hepatomegaly Yes/No
Ascites Yes/No
LABORATORY
PCV (%) ESR (mm/hr) Hypochromia
Microcytosis Macrocytosis
BIOCHEMICAL PARAMETERS (mmol/L)
Sodium Potassium Urea Bicarbonate Uric Acid Creatinine Cholesterol FBS 2HPP
Urine Microscopy (Casts) Present/Absent Cardiothoracic Ratio
Weight (Kg) Height (M) BMI (kg/m2)
Estimated Creatinine Clearance RESTING ECG
Rate Rhythm QRS Axis
Pwave duration (sec) PR Interval [sec]
Pwave height (mm) ORS duration (sec)
Twaves [inverted/tall) & affected leads
Qwaves [pathologic/normal] & affected leads RR interval [in sec] QTc Hypertrophy [chambers & criteria]
Conduction Abnormalities - [Type]
Ectopics Yes/No [Type]
ECHOCARDIOGRAPHY (ON ADMISSION AND AFTER 3 MONTH) M-mode Doppler M-mode Doppler Measurements Measurements Measurements Measurements --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DESCRIPTIVE REPORT DESCRIPTIVE REPORT
AETIOLOGY OF HF NYHA class on admission NYHA class after 3 months
SELF PACED EXERCISE TEST On Admission After 3month Distance Walked In 6minutes
Distance Walked In 12minutes Mortality Risk Group Classification
APPENDIX 2
Figure 1:Restrictive left ventricular filling with mitral regurgitation
regurgitationregurgi reregurgitation
Figure 2:Restrictive right ventricular filling with tricuspid
regurgitation
a
APPENDIX 3
Figure 3: Massive pericardial effusion
Figure 4:Impaired relaxation